Applications of Geneticin (G418)

1 The principle of action of geneticomycin

Genetomycin (Geneticin, G418) is an aminoglycoside antibiotic that inhibits protein synthesis by blocking peptide chain extension by binding to the 70S and 80S ribosomes in prokaryotic and eukaryotic cells. This mechanism is toxic to those including bacteria, yeast, plants, and mammalian cells. When the cells were successfully transfected and integrated with a neomycin resistance gene (such as the neo gene), the gene-encoded aminoglycoside phosphotransferase (APH (3) II) could covalently modify G418 to inactivate it, thereby conferring resistance to cells grown in selective medium containing G418.

In molecular genetic tests, G418 is one of the commonly used for stable transfection.

2 The application of geneomycin

2.1 Screening of Stable Transfected Cell Lines

  • G418 was used to screen for cells containing resistance genes (e. g., neo genes) by inhibiting protein synthesis. The aminoglycoside phosphotransferase encoded by the resistance gene inactivates G418, which conferring cell resistance to G418. Typically, the mammalian cell screening range is 200 – 2000 μg/mL, with the most commonly used working concentration of 100 – 700 μ g / mL. Where plant cells are 10-100 μg/mL and yeast cells are 500-1000 μ g / mL, the following are the concentrations used for some cell types using G418 for reference.

Cell

Application

Activation concentration of geneomycin(μg/mL)

 Works cited

Mucor species

a) Cultured in growth medium

b) Cultured on lyophilized bacteria

a) 10 μg/mL
b) 30 μg/mL

Hirth,et. al., Proc. Natl. Acad. Sci., v. 79, 7356-7360 (1982).

Mammalian

a) For screening

b) For maintaining growth

a) 400 -1000 μg/mL
b) 200 μg/mL

Canaani and Berg, Proc. Natl. Acad. Sci., v. 79, 5166-5170 (1982).

Plant

a) For screening

b) For maintaining growth

a) 25-50 μg/mL
b) 10 μg/mL

Ursic, et. al., Biochem. Biophys. Res. Comm., v. 101:3, 1031-1037 (1981).

Yeast

a) For screening

b) For maintaining growth

a) 500 μg/mL

b) 125-200 μg/mL

Jimenez and Davies, Nature, v. 287, 869-871 (1980).

Bacteria

For screening

16 μg/mL

Waitz, et. al., Antimicrob. Agents Chemother., v. 6:5, 579-581 (1974).

2.2 Gene Knockout and Gene Transfer

  • In gene knockout, G418 can be used to screen cells that successfully knockout the target gene. In gene transfer, G418 facilitates the integration of foreign genes into the genome of host cells.

2.3 Resistance Selection in Cell Culture

  • During cell culture, G418 is used to screen for cells resistant to the antibiotic, which often carry specific resistance genes.

3 Relevant experimental procedures for geneomycin

3.1 Preparation of G418 Stock Solution (50 mg/mL, Active Concentration)

1) Conversion of Activity Units

Convert using the formula: (1000/A0) × A1 = A2, where A0 is the potency of G418, which varies by batch. Refer to the quality control report for the corresponding batch or the label on the bottle. A1 is the desired active concentration of G418 to be prepared. A2 is the actual powder-to-volume concentration to be weighed.

For example, if the batch of G418 has a potency of 750 U/mg and you want to prepare an active concentration of 50 mg/mL, then the actual powder concentration to be prepared is 1000/750 × 50 mg/mL = 66.67 mg/mL.

If preparing 10 mL of G418 stock solution (active concentration, 50 mg/mL), then 666.7 mg of powder is required.

  • Sterilization and Storage

Based on the actual powder weight obtained from the above conversion, add it to 10 mL of sterile deionized water to completely dissolve.

First, pre-wet a 0.22 μm syringe filter with 5 mL of sterile deionized water, removing all water. Then filter using this filter to sterilize and aliquot into small volumes for single use (e.g., 1 mL) and store at -20°C for 1 year stability.

3.2 Establishment of Kill Curve

1) Day one: Plate untransformed cells at 20-25% cell density in appropriate culture plates and incubate overnight at 37°C, CO2.

2) Set a concentration gradient within a suitable range based on cell type, selecting at least 6 concentrations (G418 is most active against cells in the division phase, so cells should be cultured for a period before adding G418), for example, for mammalian cells, set 0, 50, 100, 200, 400, 800, 1000 μg/mL.

3) Day two: Remove old culture medium and replace with freshly prepared medium containing the corresponding concentration of the drug, with three replicates for each concentration.

4) Replace with fresh drug-containing medium every 3-4 days.

5) Perform live cell counts at fixed intervals (e.g., every 2 days) to determine the appropriate concentration that prevents the growth of untransfected cells. Select the lowest concentration that can kill the majority of cells within the ideal number of days (usually 7-10 days) as the working concentration for stable transfected cell line screening.

3.3 Screening of Stable Transfected Cells

  • The G418 Geneticin (60220ES) provided by Yisheng Biotech has an efficacy of ≥720 U/mg, a purity of ~98%, and batch stability, with a price nearly one-third of other companies' G418 products.
  • The screening medium containing the drugs was replaced every 3-4 days.
  • The formation of cell clones (colonies) was observed and assessed after 7 days of selection. Colonies may take a week or more to form, depending on the host cell type, transfection, and screening efficacy.
  • 5-10 resistant clones were picked and transferred to 35 mm cell culture plates and further maintained with drug-containing screening medium for 7 days.
  • After changing the normal medium culture.

4 Product recommendation

The G418 Geneticin (60220ES) provided by Yeasen Biotech has an efficacy of ≥720 U/mg, a purity of ~98%, and batch stability, with a price nearly one-third of other companies' G418 products.

Specification

S*

T*

Yeasen

Yeasen advantage

Content (HPLC)

/

/

~98%

High purity

Potency (U/mg)

≥720 µg/mg

707-721 µg/mg

≥720 µg/mg

High effectiveness

Price($/5 g)

~1000

~1000

~200

 Cheapness

5 Experimental Case

In E. coli, G69 and G99 were two different batches; the concentrations of genomycin were 8 mg/L, 12 mg/L and 16 mg/L, respectively, and the effective minimum concentration was 16 mg / L, which completely inhibited the growth of miscellaneous bacteria.

Figure 1 Stability test and validation of effective concentrations of genomicin between different batches

6 Precautions

  • G418 should not be used together with other antibiotics / antifungal agents (e. g., penicillin / streptomycin) because they are competitive inhibitors of G418. Other antibiotics can also produce cross-activity.
  • When preparing G418 solution, it must be converted according to the different vitality value (potency) of G418 batch, so as to obtain the storage liquid and working liquid requiring active concentration.
  • It is possible that untransfected cells supplemented with G418 in the culture system will not be killed because of the drug concentration being too low or too dense. Alternatively, rapidly dividing cells are more likely to be killed relative to slowly proliferating cells. Control cells (not transfected) may not be killed after 5-7 days of antibiotic addition, and clones of transfected cells (resistant clonons) require 10-14 days to form.
  • Even with the killing dose of G418, the cells may continue to divide 2 – 3 times. The efficacy of G418 usually becomes apparent after 2 days.

7 Published articles with our reagents

[1] Liu S, Zhang X, Yao X, Wang G, Huang S, Chen P, Tang M, Cai J, Wu Z, Zhang Y, Xu R, Liu K, He K, Wang Y, Jiang L, Wang QA, Rui L, Liu J, Liu Y. Mammalian IRE1α dynamically and functionally coalesces with stress granules. Nat Cell Biol. 2024 Jun;26(6):917-931. doi: 10.1038/s41556-024-01418-7. (IF:21.3)

[2] Tan K, Mo J, Li M, Dong Y, Han Y, Sun X, Ma Y, Zhu K, Wu W, Lu L, Liu J, Zhao K, Zhang L, Tang Y, Lv Z. SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma. J Exp Clin Cancer Res. 2022 Dec 20;41(1):352. doi: 10.1186/s13046-022-02563-3.(IF:11.3)

8 Related Products

Product name

Cat#

Specification

Ciprofloxacin hydrochloride

60201ES05/25/60

5/25/100g

Ampicillin, Sodium Salt

60203ES10/60

10/100g

Doxycycline hyclate

60204ES03/08/25

1/5/25g

Chloramphenicol, USP Grade

60205ES08/25/60

5/25/100g

Kanamycin Sulfate

60206ES10/60

10/100g

Tetracyclin HCl Tetracycline hydrochloride (USP)

60212ES25/60

25/100g

Vancomycin Hydrochloride

60213ES60/80/90

100mg/1g/5g

Gentamycin Sulfate Salt

60214ES03/08/25

1/5/25g

Spectinomycin Hydrochloride

60215ES08

5g

Phleomycin (20 mg/mL in solution)

60217ES20/60

20/5×20mg

Blasticidin S (Blasticidin)

60218ES10/60

10/10×10mg

Nystatin

60219ES08

5g

G418 Sulfate (Geneticin)

60220ES03/08

1/5g

Puromycin (Solution 10 mg/mL)

60209ES10/50/60/76

1×1 /5 ×1 / 1 0 ×1 /50 ×1 mL

Puromycin Dihydrochloride

60210ES25/60/72/76/80

25/100/250/500 mg / 1 g

Hygromycin B (50 mg/mL)

60224ES03

1 g (20 mL)/10×1 g (20 mL)

Hygromycin B

60225ES03/10

1/10g

Erythromycin

60228ES08/25

5/25g

Timentin

60230ES07/32

3.2/10×3.2g

Aureobasidin A (AbA)

60231ES03/08/10

1/5×1/10×1mg

Polymyxin B Sulfate

60242ES03/10

1/10MU